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Abstract The purpose of this study was to assess the
technical performance and immediate procedure outcome
of a new balloon catheter in the treatment of calciﬁed
lesions in infrainguinal arterial disease. Seventy-ﬁve
patients with infrainguinal arterial disease were prospec-
tively entered into the registry. The catheter (ReeKross
Clearstream, Ireland) is a 5- to 6-Fr balloon catheter with a
rigid shaft intended for enhanced pushability. Only tech-
nical procedural outcome was recorded. Treated calciﬁed
lesions (range: 5–30 cm), assessed angiographically, were
located in the superﬁcial femoral, popliteal, and crural
arteries. In 67 patients the lesion was an occlusion.
Guidewire passage occurred subintimally in 68 patients. In
24 patients a standard balloon catheter was chosen as ﬁrst
treatment catheter: 5 failed to cross the lesion, 8 balloons
ruptured, and in 11 patients there was an inadequate dila-
tation result. In only one of the ﬁve patients did subsequent
use of the ReeKross catheter also fail in lesion crossing.
The ReeKross was successful as secondary catheter in the
other 23 cases. In 50 patients the ReeKross was used as
primary catheter. In total the ReeKross crossed the lesions
in 74 patients. After passage and dilatation with this
catheter in 73 patients (1 failed true-lumen reentry), 19
had[30% residual lesions, of which 11 were not treated
and 8 were successfully stented. No ReeKross balloons
ruptured. We conclude that in the treatment of difﬁcult
calciﬁed lesions in arterial stenotic or occlusive disease, the
choice of a high-pushability angioplasty catheter, with
more calciﬁcation-resistant balloon characteristics, like the
ReeKross, warrants consideration.
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Introduction
Although there is now a strong tendency to treat more
severe and extensive arterial occlusive disease below the
inguinal ligament percutaneously instead of surgically [1,
2], heavy intima and media calciﬁcation may inhibit bal-
loon catheter passage distally after guidewire passage,
resulting in treatment failure. In cases where intraluminal
recanalization is not possible, the now established tech-
nique of subintimal angioplasty is used in the treatment of
long vascular occlusions [3]. The latter involves crossing
the lesion using a guidewire loop technique and balloon
catheter. However, in calciﬁed lesions the advance of
devices may fail. Heavy calciﬁcations may also cause
balloon puncture. Percutaneous treatment success appears
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DOI 10.1007/s00270-008-9398-1to be limited not only by the characteristics of the involved
lesions but also by the characteristics of the traditional
balloon catheters. The failed recanalization attempt in
approximately 20% of cases [4] indicates its inability to
overcome these intrinsic vessel limitations.
We assessed the technical performance and immediate
procedure outcome of a new balloon catheter intended for
angioplasty of heavily calciﬁed arterial disease in a mul-
ticenter registry in patients with occlusive arterial disease
below the inguinal ligament.
Materials and Methods
Patients
Seventy-ﬁve patients presenting with infrainguinal stenotic
orocclusivedisease(classiﬁedasFontaineIII)scheduledfor
routine percutaneous treatment and in whom the Reekross
catheter (ClearStream Technologies Ltd., Wexford, Ireland)
wasusedaseitherprimaryorsecondaryangioplastycatheter
were entered into a multicenter registry at four European
centers from December 2006 to June 2007. The multicenter
registry was prospective and nonrandomized.
The choice of the initial angioplasty catheter to be used
for the procedure was determined by the interventional
radiologist. There were no special exclusion criteria asso-
ciated with the registry, only those related to contrast or
pregnancy. No patient demographic data were recorded,
only anatomical, procedural, and technical data. The reg-
istry did not require IRB approval. There were no
commercial interests involved in performing this study.
Device Description
The ReeKross balloon catheter is a commercially (outside
the USA) available 5- to 6-Fr over-the-wire system that
consists of a rigid shaft, which extends from the proximal
hub to the distal tip of the catheter, and an extra rugged
inﬂation lumen. The rigidity of the shaft is achieved by a
hypotubing technology. The balloon is a blend of nylon/
pebax, developed using the so-called QuadFlex technology,
which the manufacturer asserts affords the balloon with the
necessary characteristics to perform multiple inﬂations
while advancing the catheter through long occluded
lesions. Radiopaque bands indicate the location of the
balloon under ﬂuoroscopy. Balloon lengths range from 4 to
22 cm, with diameters of 2.0–6.0 mm. Rate burst pressure
is given as 14–18 atm for 4-cm-long balloons and 13–
15 atm for 8- to 22-cm-long balloons. The catheter is
available in shaft lengths of 75, 110, 130, and 140 cm and
is compatible with a guidewire of maximum 0.035-in.
diameter. According to the manufacturer, the balloon
catheter is suitable for both intraluminal and subintimal
angioplasty.
Procedure and Technical Data Collection
Data were collected on the following: location and length
of stenosis/occlusion, presence of calciﬁcation, subintimal/
intraluminal passage, primary or assisted use of the
ReeKross catheter for dilatation, number of balloon inﬂa-
tions, balloon puncture or rupture, postdilatation procedure
results, and any additional treatment performed. Dilatation
pressures were not recorded. Any technical anomalies and
adverse events occurring during the procedure were
recorded.
Results
In 67 of the 75 patients there was total occlusion. Calciﬁed
lesions were located in the superﬁcial femoral artery (SFA;
n = 36), popliteal artery (n = 23), and crural arteries
(n = 48). Lesions were located in two or more vessels in
29 patients. Median lesion lengths were 15 cm (range: 5–
25 cm) for SFA, 10 cm (5–12 cm) for popliteal artery, and
11.5 cm (5–30 cm) for crural vessels (Table 1).
An antegrade approach was used in all procedure, as
was the use of a Terumo 0.035-in. guidewire. Guidewire
passage was subintimal in 68 patients and intraluminal in 6,
and no guidewire passage was possible in 1 patient, either
intraluminal nor subintimal.
In 24 of 74 patients other balloon catheters were used
prior to the ReeKross catheter. In one patient, both the
original balloons ruptured. This resulted in 8 events of
rupture of the original balloon (all OPTA; Cordis, a J&J
Company)—of which 5 were in the SFA (average lesion
Table 1 Treated lesion locations and lengths
Length SFA
(n = 36)
Popliteal
(n = 23)
Truncal
(n = 9)
ATA
(n = 23)
ATP
(n = 4)
Peroneal
(n = 12)
Mean (cm) 14.9 9.7 3.7 16.8 11.8 10.6
Median (cm) 15.0 10.0 4.0 17.0 11.0 10.5
Range (cm) 5–25 5–12 3–41 0 –30 10–15 5–20
Note: SFA, superﬁcial femoral artery; ATA, anterior tibial artery; ATP, posterior tibial artery
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123length, 11.2 cm), 1 popliteal (12 cm), and 2 infrapopliteal
(11.0 cm)—5 failures in crossing the lesion, and 12 cases
wherein the original catheter gave an inadequate postdila-
tation result. In only one of the ﬁve patients did subsequent
use of the ReeKross catheter also fail in lesion crossing.
The ReeKross was successful in completing the procedure
as secondary catheter in the other 23 cases.
The ReeKross was used as the primary, and only,
treatment catheter in 50 patients. In one case as primary
catheter, subintimal passage across the lesion was suc-
cessful but true-lumen entry was not achieved, thus
dilatation was not performed. Therefore, in total, this
catheter crossed the lesion in 74 of 74 patients where
guidewire passage was achieved, with 73 dilatations per-
formed. Postdilatation results in 54 of these 73 patients
showed\30% residual stenosis. In the 19 patients
with[30% residual stenoses, 8 lesions were treated by
stent placement, while the remaining 11 were not treated.
With the intention to treat patients with the ReeKross
catheter as primary catheter, the technical success (no
adjunctive treatment/stent) rate was 82% (42 of 51 patients;
1 patient failed reentry, and 8 patients required a stent).
Overall, the assisted angiographic success after adjunctive
stent placement was 97% (73 of 75 patients). The average
number of inﬂations per treated patient with the ReeKross
catheter was 2.9 (range: 1–8 inﬂations). There were no
ReeKross balloon ruptures or punctures in any of the
treated patients. There were no device-related clinical
adverse events reported.
Discussion
This registry indicates that the ReeKross catheter is an
applicable instrument in potentially difﬁcult procedures in
the treatment of occluded or stenotic arterial disease, with a
low risk of technical failures and an acceptable angio-
graphic and immediate procedure outcome in the majority
of patients.
All procedures in this registry were by antegrade
approach. The stiffness of the catheter shaft makes it
unsuitable for a retrograde procedure over the bifurcation.
Although this registry study allows limited direct com-
parison to other balloon catheters, in cases where technical
failures occurred with a standard balloon catheter, it does
indicate the potential applicability of a catheter with high
pushability and equipped with a more durable balloon.
These characteristics may also have a positive effect on
limiting the procedure time in potentially difﬁcult
recanalizations.
In patients who present with severe occlusive peripheral
disease, recanalization almost always takes the subintimal
Fig. 1 (A) Patient with total occlusion of the right distal superﬁcial
femoral artery (SFA)-popliteal artery with severe calciﬁcations,
collaterals, and a patent popliteal artery; (B) subintimal passage of
the guidewire; (C) subsequent dilatation with a 5 9 120-mm balloon;
and (D) ﬁnal angiographic result
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123route, as intraluminal access is not available. This tech-
nique has allowed the treatment of lesions otherwise not
crossable using standard transluminal approaches [3, 5, 6].
In this registry, the majority of recanalizations were sub-
intimal (Fig. 1). The ReeKross catheter showed a high
immediate angiographic and procedural success rate in all
these patients, without catheter-related clinical adverse
events, thereby indicating its suitability for this procedure.
The outcome of this registry indicates that this catheter
can be a valuable addition to the arsenal of devices for
percutaneous treatment of difﬁcult heavily calciﬁed in-
frainguinal disease, possibly expanding the range of
treatable lesions. Veriﬁcation of the latter requires a pro-
spective double-blind study with conventional balloon
catheters.
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